Development of B cell memory in allergic asthma
过敏性哮喘中 B 细胞记忆的发展
基本信息
- 批准号:10642902
- 负责人:
- 金额:$ 45.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-06-15 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAffinityAgonistAirway DiseaseAllergensAllergicAllergic inflammationAnatomyAntibodiesAntibody AffinityAntibody FormationAntibody ResponseAntigensB cell repertoireB-Cell Antigen ReceptorB-Cell DevelopmentB-Lymphocyte SubsetsB-LymphocytesBacterial InfectionsBiologyCCL20 geneCCR6 geneCell Adhesion MoleculesCellsCharacteristicsCirculationDevelopmentDisease ProgressionEffector CellExposure toExtrinsic asthmaGene Expression ProfileGenerationsGenetic TranscriptionGoalsHeterogeneityHomingHumanIgEIgG1Immune responseImmunoglobulin Class SwitchingImmunoglobulin GImmunoglobulin MImmunoglobulin-Secreting CellsImmunologic MemoryInfectionInflammationInterceptLungLymphoid TissueMediatingMemory B-LymphocyteMicroscopyMucous MembraneMusOutputParabiosisPathogenicityPatientsPhenotypePlasma CellsPopulationPositioning AttributePrevalenceProductionPulmonary InflammationRespiratory distressSignal TransductionSiteSpleenStructure of germinal center of lymph nodeTestingTissuesVirus Diseasesanti-CD20chemokine receptorchronic inflammatory diseasechronic inflammatory lung diseaseconstrictionexperimental studyimmune functionlymphoid organlymphoid structuresmouse modelnovel therapeutic interventionresponsesensitizing antigentraffickingtranscriptomics
项目摘要
Project Summary/Abstract
Allergic asthma is a chronic inflammatory disease of the lungs without cure. Repetitive allergen exposure in the
airway leads to the generation of pathogenic immune memory and the excessive production of allergen specific
IgE antibodies that mediate inflammation, airway constriction and respiratory distress in patients with allergic
asthma. Memory B cells are a key component of immune memory. The phenotypic and functional heterogeneity
of MBCs affords their differential antibody responses as well as impact their trafficking, tissue retention and ability
to disseminate systemically. In a mouse model of allergic lung inflammation, we have observed stable lung-
localized MBCs and evidence for the generation of pathogenic antibody responses in sensitized lungs. We
hypothesize that after local antigen sensitization, the lung acquires immune functions reminiscent of those in
secondary lymphoid tissues, capable of maintaining long-lived memory B cells as well as generating new MBCs
that can recirculate and disseminate in other tissues to mediate systemic allergic inflammation. In this study, we
will 1) probe the development of memory B cells (MBCs) in allergic lungs including in-depth characterization of
the critical MBC subset that contributes to allergen specific IgE response, and 2) how these MBCs disseminate
systemically. We will also 3) explore strategies to intercept the systemic dissemination of pathogenic MBCs to
halt the progression of allergic inflammation. These studies will advance our fundamental understanding of
memory B cells as well as help devise new therapeutic strategies for allergic asthma.
项目概要/摘要
过敏性哮喘是一种无法治愈的慢性肺部炎症性疾病。反复接触过敏原
气道导致致病性免疫记忆的产生和过敏原特异性的过度产生
IgE 抗体介导过敏患者的炎症、气道收缩和呼吸窘迫
哮喘。记忆 B 细胞是免疫记忆的关键组成部分。表型和功能异质性
MBC 的数量提供了不同的抗体反应,并影响其运输、组织保留和能力
系统地传播。在过敏性肺部炎症的小鼠模型中,我们观察到稳定的肺
局部 MBC 和致敏肺部产生致病性抗体反应的证据。我们
假设局部抗原致敏后,肺获得了类似于肺的免疫功能
次级淋巴组织,能够维持长寿的记忆 B 细胞并产生新的 MBC
它可以在其他组织中再循环和传播,从而介导全身过敏性炎症。在这项研究中,我们
将 1) 探索过敏性肺部中记忆 B 细胞 (MBC) 的发育,包括深入表征
有助于过敏原特异性 IgE 反应的关键 MBC 子集,以及 2) 这些 MBC 如何传播
系统地。我们还将 3) 探索拦截致病性 MBC 系统性传播的策略
阻止过敏性炎症的进展。这些研究将增进我们对以下问题的基本理解:
记忆 B 细胞还有助于制定过敏性哮喘的新治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yee Ling Wu其他文献
Molecular basis of complement C1r deficiency in a male African American patient with systemic lupus erythematosus
- DOI:
10.1016/j.molimm.2010.05.072 - 发表时间:
2010-08-01 - 期刊:
- 影响因子:
- 作者:
Yee Ling Wu;Blake Brookshire;Chack-Yung Yu;Frank Arnett - 通讯作者:
Frank Arnett
Low gene copy-number of complement C4A, the presence of HLA-DR3, and the presence of HLA-DR2 are independent and additive risk factors for human systemic lupus erythematosus
- DOI:
10.1016/j.molimm.2010.05.259 - 发表时间:
2010-08-01 - 期刊:
- 影响因子:
- 作者:
Yee Ling Wu;Emeli Lundstrom;Chau-Ching Liu;Yan Yang;Iva Gunnarsson;Elisabet Svenungsson;Bi Zhou;Karla N. Jones;Haikady N. Nagaraja;Gloria C. Higgins;Charles Spencer;Hermine Brunner;Dan J. Birmingham;Brad H. Rovin;Betty P. Tsao;Joseph M. Ahearn;Lee A. Hebert;Leonid Padyukov;C. Yung Yu - 通讯作者:
C. Yung Yu
Lung-resident memory B cells maintain allergic IgE responses in the respiratory tract
肺驻留记忆 B 细胞维持呼吸道中的过敏性 IgE 反应
- DOI:
10.1016/j.immuni.2025.03.001 - 发表时间:
2025-04-08 - 期刊:
- 影响因子:26.300
- 作者:
Alexander J. Nelson;Bruna K. Tatematsu;Jordan R. Beach;Dorothy K. Sojka;Yee Ling Wu - 通讯作者:
Yee Ling Wu
Yee Ling Wu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yee Ling Wu', 18)}}的其他基金
Development of B cell memory in allergic asthma
过敏性哮喘中 B 细胞记忆的发展
- 批准号:
10503760 - 财政年份:2022
- 资助金额:
$ 45.43万 - 项目类别:
Investigation of memory B cell response in asthmatic lungs.
哮喘肺部记忆 B 细胞反应的研究。
- 批准号:
10413232 - 财政年份:2021
- 资助金额:
$ 45.43万 - 项目类别:
Investigation of memory B cell response in asthmatic lungs.
哮喘肺部记忆 B 细胞反应的研究。
- 批准号:
10303811 - 财政年份:2021
- 资助金额:
$ 45.43万 - 项目类别:
Studies of Antibody Diversity and Genome Stability: Regulation of Activation-Indu
抗体多样性和基因组稳定性的研究:激活诱导的调节
- 批准号:
8591624 - 财政年份:2010
- 资助金额:
$ 45.43万 - 项目类别:
Studies of Antibody Diversity and Genome Stability: Regulation of Activation-Indu
抗体多样性和基因组稳定性的研究:激活诱导的调节
- 批准号:
8002358 - 财政年份:2010
- 资助金额:
$ 45.43万 - 项目类别:
Studies of Antibody Diversity and Genome Stability: Regulation of Activation-Indu
抗体多样性和基因组稳定性的研究:激活诱导的调节
- 批准号:
8374091 - 财政年份:2010
- 资助金额:
$ 45.43万 - 项目类别:
Studies of Antibody Diversity and Genome Stability: Regulation of Activation-Indu
抗体多样性和基因组稳定性的研究:激活诱导的调节
- 批准号:
8125086 - 财政年份:2010
- 资助金额:
$ 45.43万 - 项目类别:
Studies of Antibody Diversity and Genome Stability: Regulation of Activation-Indu
抗体多样性和基因组稳定性的研究:激活诱导的调节
- 批准号:
8409854 - 财政年份:2010
- 资助金额:
$ 45.43万 - 项目类别:
Studies of Antibody Diversity and Genome Stability: Regulation of Activation-Indu
抗体多样性和基因组稳定性的研究:激活诱导的调节
- 批准号:
8128051 - 财政年份:2010
- 资助金额:
$ 45.43万 - 项目类别:
相似海外基金
Discovery of a High Affinity, Selective and β-arrestin Biased 5-HT7R Agonist
发现高亲和力、选择性和β-抑制蛋白偏向的 5-HT7R 激动剂
- 批准号:
10412227 - 财政年份:2022
- 资助金额:
$ 45.43万 - 项目类别:
Discovery of a High Affinity, Selective and β-arrestin Biased 5-HT7R Agonist
发现高亲和力、选择性和β-抑制蛋白偏向的 5-HT7R 激动剂
- 批准号:
10610473 - 财政年份:2022
- 资助金额:
$ 45.43万 - 项目类别:
Supplement to Discovery of a high affinity, selective and beta-arrestinbiased 5-HT7R Agonist Grant
对高亲和力、选择性和 β 抑制偏向 5-HT7R 激动剂发现的补充补助金
- 批准号:
10799162 - 财政年份:2022
- 资助金额:
$ 45.43万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6639179 - 财政年份:2001
- 资助金额:
$ 45.43万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6724797 - 财政年份:2001
- 资助金额:
$ 45.43万 - 项目类别:
General Anesthetics and nAcCHOR Agonist Affinity
全身麻醉药和 nAcCHOR 激动剂亲和力
- 批准号:
6636512 - 财政年份:2001
- 资助金额:
$ 45.43万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6266928 - 财政年份:2001
- 资助金额:
$ 45.43万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6539099 - 财政年份:2001
- 资助金额:
$ 45.43万 - 项目类别:
General Anesthetics and nAcCHOR Agonist Affinity
全身麻醉药和 nAcCHOR 激动剂亲和力
- 批准号:
6326889 - 财政年份:2001
- 资助金额:
$ 45.43万 - 项目类别:
General Anesthetics and nAcCHOR Agonist Affinity
全身麻醉药和 nAcCHOR 激动剂亲和力
- 批准号:
6520329 - 财政年份:2001
- 资助金额:
$ 45.43万 - 项目类别:














{{item.name}}会员




